Article

Pharmaceutical Executive

Pharmaceutical Executive

Pharmaceutical Executive-12-01-2012
Volume0
Issue 0

Pharmaceutical Executive Digital Edition - December 2012

The Puzzle Master

Articles in this issue
Pharmaceutical Executive Digital Edition - December 2012
i1-799842-1408598794129.jpg
Obamacare, Innovation and Pricing
i4-799843-1408598790050.jpg
Germany's Price Reform Revolution
Transforming Drug Development: A Lilly–Covance Case Study
Transforming Drug Development: A Lilly–Covance Case Study
i1-799841-1408598796971.jpg
The Puzzle Master: EMA's Guido Rasi
Top Medical Innovations for 2013

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!
Related Videos
Derrick Gastineau
Noah Nasser
Related Content
Lamine Mbow
August 28th 2025

Leading Science-Driven Organizations: Q&A with Lamine Mbow

Mike Hollan
The Rx for High-Performance Leadership: Cutting Through the Chaos
August 28th 2025

The Rx for High-Performance Leadership: Cutting Through the Chaos

Michael Christel
Credit: Tada Images | stock.adobe.com, The FDA has authorized the use of updated COVID-19 vaccines for the upcoming fall season, with eligibility limited to adults aged 65 years and older as well as individuals who have at least one underlying medical condition that places them with a high risk for severe COVID-19
August 28th 2025

FDA Authorizes New COVID Vaccines with Restrictions on Eligibility

Davy James
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
August 28th 2025

Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research

Miranda Schmalfuhs
Stock.adobe.com
August 28th 2025

Pfizer to Lay Off 100 Employees from Former Seagen HQ Amid Cost Cuttings

Nicholas Jacobus
EVERSANA and Waltz Health Unite to Address Drug Pricing and Access Issues
August 28th 2025

EVERSANA and Waltz Health Unite to Address Drug Pricing and Access Issues

Nicholas Saraceno, Editor